Eisenberger MA - Search Results

1

A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.

Markowski MC, Tutrone R, Pieczonka C, Barnette KG, Getzenberg RH, Rodriguez D, Steiner MS, Saltzstein DR, Eisenberger MA, Antonarakis ES. Markowski MC, et al. Among authors: eisenberger ma. Clin Cancer Res. 2022 Jul 1;28(13):2789-2795. doi: 10.1158/1078-0432.CCR-22-0162. Clin Cancer Res. 2022. PMID: 35416959 Free PMC article. Clinical Trial.

2

Chemotherapy for endocrine resistant cancer of the prostate.

Eisenberger MA. Eisenberger MA. Prog Clin Biol Res. 1990;359:155-64; discussion 177-80. Prog Clin Biol Res. 1990. PMID: 2284289 Review. No abstract available.

3

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.

Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jodrell DI, Zuhowski EG, Tkaczuk KH, Lowitt MH, Hemady RK, Jacobs SC, et al. Eisenberger MA, et al. J Clin Oncol. 1995 Sep;13(9):2174-86. doi: 10.1200/JCO.1995.13.9.2174. J Clin Oncol. 1995. PMID: 7666076 Clinical Trial.

4

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin.

Reyno LM, Egorin MJ, Eisenberger MA, Sinibaldi VJ, Zuhowski EG, Sridhara R. Reyno LM, et al. Among authors: eisenberger ma. J Clin Oncol. 1995 Sep;13(9):2187-95. doi: 10.1200/JCO.1995.13.9.2187. J Clin Oncol. 1995. PMID: 7666077 Clinical Trial.

5

Suramin, an active drug for prostate cancer: interim observations in a phase I trial.

Eisenberger MA, Reyno LM, Jodrell DI, Sinibaldi VJ, Tkaczuk KH, Sridhara R, Zuhowski EG, Lowitt MH, Jacobs SC, Egorin MJ. Eisenberger MA, et al. J Natl Cancer Inst. 1993 Apr 21;85(8):611-21. doi: 10.1093/jnci/85.8.611. J Natl Cancer Inst. 1993. PMID: 8468719 Clinical Trial.

6

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.

Sridhara R, Eisenberger MA, Sinibaldi VJ, Reyno LM, Egorin MJ. Sridhara R, et al. Among authors: eisenberger ma. J Clin Oncol. 1995 Dec;13(12):2944-53. doi: 10.1200/JCO.1995.13.12.2944. J Clin Oncol. 1995. PMID: 8523059

7

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, Wilding G, Sears K, Culkin DJ, Thompson IM Jr, Bueschen AJ, Lowe BA. Eisenberger MA, et al. N Engl J Med. 1998 Oct 8;339(15):1036-42. doi: 10.1056/NEJM199810083391504. N Engl J Med. 1998. PMID: 9761805 Free article. Clinical Trial.

8

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.

Laufer M, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: eisenberger ma. Urology. 1999 Oct;54(4):745. doi: 10.1016/s0090-4295(99)00268-x. Urology. 1999. PMID: 10754148 Free article.

9

Complete androgen blockade for prostate cancer: what went wrong?

Laufer M, Denmeade SR, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: eisenberger ma. J Urol. 2000 Jul;164(1):3-9. J Urol. 2000. PMID: 10840412 Free article. Review.

10

A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.

Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, Zabelina Y, Chen TL, Grochow LB, Donehower RC. Carducci MA, et al. Among authors: eisenberger ma. Clin Cancer Res. 2001 Oct;7(10):3047-55. Clin Cancer Res. 2001. PMID: 11595694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page